Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
AIDS Patient Care and Stds
|
November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis
Lentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
Oncotarget
|
November 29, 2017
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
Jose Mauricio Mota, Katharine Ann Collier, Ricardo Lima Barros Costa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 11, 2023
Incidence and Predictors of Pregnancy in Women Enrolled in Large Multinational HIV Treatment Trials of the AIDS Clinical Trials Group
Ayotunde E Omoz-Oarhe, Michael D Hughes, Bao Yajing, et al.
Journal of Clinical and Experimental Neuropsychology
|
March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change
Lucette A Cysique, Donald Franklin, Ian Abramson, et al.
AIDS (London, England)
|
February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects
Ignacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
Archives of Neurology
|
May 12, 2010
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study
Ronald J Ellis, Debralee Rosario, David B Clifford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 7, 2005
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study)
Andrew R Zolopa, Laura C Lazzeroni, Alex Rinehart, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1
David Croteau, Scott Letendre, Brookie M Best, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, et al.
Journal of Affective Disorders
|
July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individuals
Jayraan Badiee, David J Moore, J Hampton Atkinson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
AIDS Patient Care and Stds
|
November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis
Lentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
Oncotarget
|
November 29, 2017
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
Jose Mauricio Mota, Katharine Ann Collier, Ricardo Lima Barros Costa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 11, 2023
Incidence and Predictors of Pregnancy in Women Enrolled in Large Multinational HIV Treatment Trials of the AIDS Clinical Trials Group
Ayotunde E Omoz-Oarhe, Michael D Hughes, Bao Yajing, et al.
Journal of Clinical and Experimental Neuropsychology
|
March 11, 2011
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change
Lucette A Cysique, Donald Franklin, Ian Abramson, et al.
AIDS (London, England)
|
February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects
Ignacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
Archives of Neurology
|
May 12, 2010
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study
Ronald J Ellis, Debralee Rosario, David B Clifford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 7, 2005
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study)
Andrew R Zolopa, Laura C Lazzeroni, Alex Rinehart, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1
David Croteau, Scott Letendre, Brookie M Best, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, et al.
Journal of Affective Disorders
|
July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individuals
Jayraan Badiee, David J Moore, J Hampton Atkinson, et al.
Page
of 3